Meet the 2022 Foreign Company of the Year Finalists!
AmCham Denmark is pleased to announce the finalists for the 2022 Foreign Company of the Year. We congratulate these outstanding companies and wish them well as AmCham’s independent jury evaluates their accomplishments. The winner will be announced at AmCham’s 2022 Fall Member Dinner at Moltkes Palæ on October 11.
The finalists are:
Agilent Technologies is a global leader in life sciences, diagnostics and applied chemical markets, delivering insight and innovation toward improving the quality of life. Agilent’s full range of solutions includes instruments, software, services, and expertise that provide trusted answers to their customers’ most challenging scientific questions. The company generated revenue of $6.32 billion in fiscal 2021 and employs 18,000 people worldwide. Whether working with customers to keep food supplies safe, improve the quality of air, water and soil, or fight cancer with more precise diagnoses and targeted treatments, Agilent employees share a passion and commitment to advancing the quality of life.
BASF creates chemistry for a sustainable future, combining economic success with environmental protection and social responsibility. Over 111,000 employees contribute worldwide to the success of around 90,000 customers in nearly all sectors. As the largest chemical company in the world, BASF is a leader in the industry. This applies especially to the transformation to climate neutrality, where their goal is to reduce CO2 emissions 25% worldwide by 2030 compared with 2018, with an ultimate target of net zero emissions by 2050. In 2021, BASF generated sales of €78.6 billion.
Cook Medical invents, manufactures, and delivers a unique portfolio of medical devices to improve the quality of life of patients worldwide. Serving patients is a privilege, and Cook demands the highest standards of quality, ethics, and service. Cook Medical has etched a permanent, historical, and influential mark in the field of minimally invasive medicine. In 1963, William A. Cook founded Cook Incorporated and manufactured the first U.S.-produced percutaneous wire guides and catheters assisted by his wife, Gayle. Since then, Cook has evolved into a prosperous, global MedTech company now supporting almost 60 clinical specialties, while still maintaining a second-to-none family culture.
FMC Corporation is a global agricultural sciences company dedicated to helping growers produce food, feed, fiber and fuel for an expanding world population while adapting to a changing environment. FMC’s innovative crop protection solutions – including biologicals, crop nutrition, digital and precision agriculture – enable growers, crop advisers and turf and pest management professionals to address their toughest challenges economically while protecting the environment. FMC recently acquired BioPhero, a pioneer in the production of pheromones used for insect pest control in agriculture.
Microsoft works to leverage technology to empower welfare, growth, and the green transition in Denmark. With more than 4.000 local partners, Microsoft’s technology helps accelerate digital transformation across large companies, SMEs, public sector, education, and civil society. Microsoft invests deeply in R&D in Denmark, recently consolidating its quantum research, making Lyngby Microsoft’s largest quantum hub outside the U.S. Microsoft is establishing a Danish datacenter region, supplied by 100 % renewable energy, to ensure direct, secure and sustainable access to Microsoft Cloud for Danish customers. As part of Microsoft’s societal commitment, they are upskilling more than 200,000 Danes to ensure that everyone is onboard in the digital future. This reflects Microsoft’s global mission to empower every person and every organization on the planet to achieve more.
MSD – known as Merck & Co in the U.S. – is one of the largest innovative pharmaceutical companies in the world as well as in Denmark. With a strong focus on innovation, scientific excellence and social responsibility, MSD aims to use the power of leading-edge science to save and improve lives around the world. MSD believes in its responsibility to deliver healthier tomorrows through vaccines and medications within oncology, hospital, specialty and chronic care that can help patients and communities around the world. MSD strives to operate responsibly every day through local and global partnerships with a wide range of public, private, and NGO partners, including the fight against public health threats like maternal mortality and the Ebola virus.
To read more about AmCham’s Foreign Company of the Year, click here.